Trial Profile
RIM - Rituximab in Maintenance
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Sponsors Roche
- 04 Sep 2015 New trial record